If you’re taking weight-loss medication and thinking about having a baby, speak to your prescriber first. GLP-1 medicines should not be used during pregnancy or while trying to conceive, and most need to be stopped weeks or months before you start trying. Wegovy, Mounjaro and Foundayo each have different stopping periods and contraceptive advice.
If you’ve only just found out you’re pregnant, there’s no need to panic, but do get prompt advice about the medicine you’ve been taking. If you’re still planning, talk to your prescriber before you start trying, rather than relying on a timetable meant for a different medicine.
Table of Contents
1. Why shouldn’t you use GLP-1 medicines during pregnancy?
2. How long before trying for a baby should you stop taking weight-loss medication?
3. Can these medicines affect the contraceptive pill?
4. What if you discover you’re pregnant during treatment?
5. Do weight-loss medicines make you more fertile?
6. What about breastfeeding and restarting afterwards?
7.1. Can you use Wegovy tablets while pregnant?
7.2. How long should you stop Foundayo before trying to conceive?
7.3. Do you need extra contraception when starting Foundayo?
7.4. What if you took a dose before knowing you were pregnant?
Why shouldn’t you use GLP-1 medicines during pregnancy?
There isn’t enough safety information to know whether these medicines could harm an unborn baby, and some animal studies have found harmful effects on the foetus. They should not be used to manage weight during pregnancy. Mounjaro works slightly differently, acting on both GIP and GLP-1 receptors, but the same pregnancy advice applies.
The NHS advises against trying to lose weight during pregnancy. Your maternity team can advise on healthy eating, physical activity and any extra monitoring you need. In pregnancy, the focus is on your health and your baby’s, not on continuing your weight loss.
How long before trying for a baby should you stop taking weight-loss medication?
The stopping period allows time for the medicine to leave your body before a planned pregnancy. The table below shows the stopping period for each treatment discussed here. Your prescriber can help you plan the change and choose suitable contraception for the waiting period. Count from your last dose, not from the date of your last prescription.
The two-month advice for semaglutide applies to Wegovy tablets as well as injections, and Foundayo’s three-week interval is shorter than Mounjaro’s one month. Switching to a tablet doesn’t remove the need to plan ahead, and you shouldn’t change your dose or switch formats without clinical advice. Our Wegovy tablet information and Foundayo information pages explain more about each treatment, but your prescriber should guide your pregnancy planning.
| Medicine | Stop before a planned pregnancy | Source |
|---|---|---|
| Wegovy: semaglutide tablets or injections | At least 2 months | MHRA and Wegovy leaflet |
| Mounjaro: tirzepatide | At least 1 month | MHRA guidance |
| Foundayo: orforglipron | At least 3 weeks | Foundayo leaflet |
Can these medicines affect the contraceptive pill?
If you take the contraceptive pill, Mounjaro’s leaflet advises also using a barrier method, such as condoms, or switching to a non-oral method for four weeks after starting treatment and for four weeks after each dose increase. Foundayo carries a similar warning, covering 30 days after starting and after each dose increase.
These instructions are specific to each medicine, so don’t assume every GLP-1 affects the pill in the same way. The MHRA notes that GLP-1 medicines may make oral contraceptives less effective in people who are overweight, so check your contraception with a clinician even if you use Wegovy. Vomiting and diarrhoea, which are common side effects, can also stop the pill working properly, so follow your pill leaflet and get advice if they happen.
If your contraception may have failed and you’ve had sex that could lead to pregnancy, contact a pharmacist or sexual health service promptly about emergency contraception. Tell them which medicine you take, your dose and when you last took it. Don’t wait until you miss a period.
What if you discover you’re pregnant during treatment?
If you’re taking a GLP-1 for weight loss, stop taking it and contact your prescriber and maternity team promptly. Make a note of the medicine, your last dose and when you think you became pregnant. If you take it for diabetes, speak to your diabetes team promptly about switching to another treatment, as keeping your blood sugar under control is important in pregnancy.
Taking a GLP-1 in early pregnancy before you knew doesn’t mean your baby has been harmed. BUMPS, the UK’s medicines-in-pregnancy information service, describes information from around 47,000 women exposed in early pregnancy as reassuring, although it says more research is needed. This doesn’t mean it’s safe to keep taking these medicines, and the evidence may be more limited for newer ones.
You don’t need to work out the risk alone. Give your care team the details and let them explain what follow-up is appropriate, rather than relying on online forums.
Do weight-loss medicines make you more fertile?
Stories of unexpected pregnancies don’t mean these medicines are fertility treatments. Weight loss, underlying health conditions, contraception and individual circumstances can all play a part. If you’ve struggled to conceive in the past, don’t assume you don’t need contraception now.
If you want to improve your health before trying for a baby, talk to your GP and prescriber about timing. They can help you plan when to stop treatment and what support you’ll need afterwards. A weight-loss medicine shouldn’t be used as an unplanned fertility treatment.
What about breastfeeding and restarting afterwards?
The MHRA advises that GLP-1 medicines should not be taken while breastfeeding, and the Wegovy tablets and Foundayo leaflets both say not to use them while breastfeeding. The Mounjaro leaflet asks you to talk to your doctor first, so if you’re breastfeeding or planning to, discuss any GLP-1 with your prescriber before using it.
After giving birth, don’t restart leftover medication without a new assessment, even if it suited you before pregnancy. Your feeding plans, your health and how long you’ve been off treatment can all change what’s appropriate. Pharmacy Planet’s weight-loss treatment information explains how our assessment works, but your postnatal care should come first.
Frequently asked questions
Can you use Wegovy tablets while pregnant?
No. Wegovy tablets should not be used during pregnancy, and the leaflet advises stopping at least two months before a planned pregnancy. Taking semaglutide as a tablet rather than an injection doesn’t make it safe in pregnancy. If you become pregnant while taking it, stop and contact your prescriber promptly.
How long should you stop Foundayo before trying to conceive?
Foundayo’s UK leaflet advises stopping at least three weeks before a planned pregnancy. Talk to your prescriber about stopping treatment and about contraception before you start trying. This is shorter than the two months advised for Wegovy and the one month for Mounjaro, so don’t use another medicine’s timetable.
Do you need extra contraception when starting Foundayo?
If you use the contraceptive pill, Foundayo’s leaflet advises also using a barrier method or switching to a non-oral method for 30 days after starting and for 30 days after each dose increase. Ask a clinician about the best method for you, and tell them if you have vomiting or diarrhoea, as this can also affect the pill.
What if you took a dose before knowing you were pregnant?
If you take a GLP-1 for weight loss, stop and contact your prescriber and maternity team, telling them which medicine you took and when you had your last dose. If you take it for diabetes, speak to your diabetes team promptly about switching treatment. Information on accidental early exposure is reassuring, but it doesn’t mean it’s safe to carry on taking these medicines.
Can you take weight-loss tablets while breastfeeding?
The UK leaflets for Wegovy tablets and Foundayo both say not to use them while breastfeeding. Don’t restart a previous prescription on your own after giving birth. Talk to your clinician about your feeding plans, your health and the right timing, so that any future weight-loss treatment suits your circumstances.
Sources and further reading
MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know
eMC: Wegovy tablets patient information leaflet
eMC: Mounjaro patient information leaflet
eMC: Foundayo patient information leaflet
BUMPS: GLP-1 receptor agonists in pregnancy
NHS: What to do if you’re sick or have diarrhoea when taking the combined pill